The Role of GIP in New Weight Loss Medications Tirzepatide (Mounjaro) Tirzepatide is a GIP and GLP-1 receptor agonist approved for the treatment of type 2 diabetes and studied extensively for obesity
If you are traveling for only a few days, many branded pens can be kept at room temperature, as long as they stay below 86F
Learn more about how these therapies fit into the broader landscape in our guide to the best peptides for weight loss
Bioscience Employers list, including: API , Gotcare , Health Cities , Neuraura , Northern RNA , and Providence Therapeutics Cubresa has filed its first FDA 510(k) premarket notification for the BrainPET system
Orforglipron, if successful, could broaden access and sharpen competition in one of pharmas hottest markets, pressure already visible as Novo announced 9,000 job cuts amid intensifying rivalry